Better Buy: Eli Lilly vs. Pfizer

Eli Lilly (NYSE: LLY) and Pfizer (NYSE: PFE) have been two of the best-performing big pharma stocks over the past decade. Nonetheless, these two pharma titans have both run into serious trouble this year due to a mix of patent woes, headwinds from restructuring, and the raging prescription drug-pricing debate in the United States.

Which of these top pharma stocks is better positioned to rebound in 2020? To answer this all-important question, let's take a look at their respective product portfolios, late-stage clinical pipelines, and near-term growth prospects.

Image source: Getty Images.

Source Fool.com